Health & Healthcare

A new white paper published by Deloitte offers new insights on how the evolution of well-being in the workplace is pushing employers to take an integrated approach to establishing a culture that helps support employees’ overall physical and mental well-being.

Gilead HIV Policy Directors Dan Murphy and Pema McGuinness recently developed a series of policy papers that warn of the consequences if governments fail to take steps to prioritize and invest in HIV.

At CooperCompanies, our mission of improving lives one person at a time is grounded in enhancing health and wellness worldwide. For us, it’s not just business. It’s deeply personal.

Abbott was recently recognized as an industry leader on The Global Child Forum’s State of Children's Rights and Business Global Benchmark 2021 for implementing policies and practices that address and protect the rights of children.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced the signing of a long-term supply agreement with the United Nations Children’s Fund (UNICEF) to facilitate broad global access for molnupiravir, an investigational

In 1999, with the country ravaged by HIV and its future existence literally in doubt, Botswana embarked on an aggressive plan to curtail the transmission of the virus from mother to child.

The Dr. Martin Luther King, Jr. holiday marks a National Day of Service and an important time of reflection. In 1966 Rev. Dr. Martin Luther King, Jr. spoke at the National Convention of the Medical Committee for Human Rights

Northern Trust is helping to fund a $4.75 million comprehensive home-based asthma program, known as the New York Healthy Homes Collaborative, to improve quality of life for 850 New York City children and adults on Medicaid.

As a middle school math teacher in Woodbridge, Virginia, Dr. Arik King saw firsthand how boys of color trailed their peers in test scores, attendance, and graduation rates—part of an alarming and persistent national trend.

Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) for several programs in Boehringer Ingelheim's oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer.